The aim of the study was to define with more precision indications for prophylactic platelet transfusions in patients with acute myeloid leukemia and chemotherapy-induced thrombocytopenia. 22 patients with "de novo" acute myeloid leukemia were included. The median age was 53,5 years (range 24-72). The basic unit for statistical assessment was 1 day. 1868 days were assessed. This study concerned following parts: 1. Bleeding according to the degree of thrombocytopenia; 2. Bleeding according to the influence of several clinical factorsAvailable from STL Prague, CZ / NTK - National Technical LibrarySIGLECZCzech Republi
To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.